Time on boards
- Boards served
- 4
- Current seats
- 4
- Board service
- 10 years
- Director since
- 2023
10 years of board service in total across 4 boards, counting each seat separately. Longest: AnaptysBio Inc., 3 years.
AnaptysBio Inc.
Director
Scilex Holding Company
Director
Jazz Pharmaceuticals plc
Director
Fate Therapeutics Inc.
Director
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Fate Therapeutics Inc. June 12, 202699.7%
-
Jazz Pharmaceuticals plc July 25, 202497.4%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 31, 2026 | Jazz Pharmaceuticals plc | Shares withheld for tax | −14 | $244.06 | $3,417 |
| Aug 31, 2026 | Jazz Pharmaceuticals plc | Shares withheld for tax | −1,692 | $241.39 | $408,432 |
| Aug 5, 2026 | Jazz Pharmaceuticals plc | Grant or award | +1,605 | — | — |
| Aug 8, 2025 | Jazz Pharmaceuticals plc | Shares withheld for tax | −1,805 | $111.25 | $200,806 |
| Aug 7, 2025 | Jazz Pharmaceuticals plc | Grant or award | +3,507 | — | — |
| Aug 2, 2024 | Jazz Pharmaceuticals plc | Grant or award | +3,731 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.